NLS Medtech News

Editor’s Pick – September 3, 2024

“Keep learning and great ideas will follow”

Fertram Sigurjonsson’s company Kerecis is dedicated to producing and commercializing fish skin for medical purposes. Recently, the company became one of Iceland’s first unicorns when it was acquired by Danish medtech giant Coloplast.

Financing – October 2, 2024

Senzime carries out a directed share issue of SEK 86 million

The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.

MedTech Business – September 20, 2024

Medical vest aims to enable cancer treatment for children

For seriously ill children and adolescents, intravenous drip stands can significantly hinder mobility.

Acquisition – August 23, 2024

Getinge to acquire Paragonix Technologies

Getinge has announced an agreement to acquire 100% of Paragonix Technologies for an aggregated purchase price, including upfront and earn out payments, estimated to approximately USD 477 million. The acquisition aligns with Getinge’s broader strategy to expand its portfolio into high growth markets that complement and enhance its acute heart and lung support offering already […]

MedTech Business – August 21, 2024

AlgoDx receives FDA clearance

AlgoDx has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its sepsis detection software using an algorithm, NAVOY CDS. This milestone marks a major step forward in AlgoDx’s expansion into the U.S. market, states the company. NAVOY CDS NAVOY CDS is a software as a medical device (SaMD) designed to support […]

Clinical trials

Clinical Trials Medtech – October 1, 2024

Elekta presents promising initial results from the UNITED trial

Jay Detsky, radiation oncologist at Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada, has presented initial cancer control outcomes from the UNITED trial (Unity-Based MR-Linac Guided Adaptive Radiotherapy for High Grade Glioma).

Clinical Trials Medtech – January 16, 2024

OssDsign reports new clinical study data

OssDsign has announced that positive data from the clinical study TOP FUSION has been submitted to a peer-reviewed scientific journal. Top-line results show a 93 % spinal fusion rate at 12 months as assessed with CT by independent radiological review from Medical Metrics Inc. after surgery with the novel nanosynthetic bone graft OssDsign Catalyst, states […]

Clinical Trials – October 23, 2023

Spago Nanomedical to initiate phase I/IIa study in Australia

The company’s application to start the clinical phase I/IIa study, Tumorad-01, with the candidate drug 177Lu-SN201 in cancer patients has been approved. The first patient is expected to be included shortly, states the company. “We are very excited and strongly motivated to now start the first clinical study with Tumorad. The study is designed in […]

Clinical Trials – May 2, 2022

AI Medical Technology initiates clinical study

AI Medical Technologies announces the start of a clinical trial at 30 Swedish primary care facilities with Dermalyser, a diagnostic decision support system empowered with advanced artificial intelligence (AI). The study is a prospective, confirmatory multi-centre, non-interventional clinical investigation with the aim to evaluate the clinical safety, performance and benefit of Dermalyser in patients with […]

Clinical Trials Medtech – March 16, 2022

Otivio extends exploratory clinical trial

The Norwegian healthtech company Otivio has extended an exploratory clinical trial with Neuro-SysMed to confirm the potential of its FlowOx medical device to alleviate multiple sclerosis symptoms. The trial follows a recent case series of 7 people with MS (pwMS) conducted by neurologist Dr Gabriela Fortes where FlowOx significantly alleviated MS related spasticity and pain, […]

Clinical Trials Medtech – July 13, 2021

Chordate Medical receives CE mark approval

The company has received CE mark approval for a neuromodulation treatment of Chronic Migraine. The Swedish company’s existing EC-certificate for K.O.S has now been granted an extension with the indication Chronic Migraine and the intended use: Preventive treatment of chronic migraine in adults over 18 years. The CE marking means that the K.O.S treatment meets […]

Clinical Trials Medtech – June 22, 2020

Random Walk Imaging announces positive data

Random Walk Imaging (RWI) has announced positive data from a study in multiple sclerosis (MS) patients using the company’s scanning method and software protocol. Data from the study, which was conducted at the Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre, demonstrated a significant improvement in the sensitivity of MRI images to disease […]

Clinical Trials Medtech – November 21, 2018

Dignitana launches clinical trial in China

The company is partnering with Beijing University Cancer Hospital and Konica Minolta in a clinical trial to assess the efficacy of scalp cooling for chemotherapy-induced hair loss in women with breast cancer. Dr. Tao Ouyang, Chairman of Breast Center of Beijing University Cancer Hospital will lead the study which includes 256 patients at Beijing University Cancer Hospital over […]

Clinical Trials Medtech – November 19, 2018

Positive results from Bonesupport

The company has announced new data from the CERTiFy (CERAMENT Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft). “Successfully completing the ground-breaking CERTiFy study, to demonstrate CERAMENT BVF is non-inferior to autograft in treating tibia plateau fracture defects, is a major milestone for BONESUPPORT. We expect the results from the study […]

Clinical Trials Medtech – October 31, 2018

Positive results from a retrospective study of OSSDSIGN Cranial PSI

OssDsign AB has announced positive results from a retrospective study of OSSDSIGN Cranial PSI that has been accepted for publication in World Neurosurgery. The retrospective study carried out at Karolinska University Hospital in Sweden describes the clinical outcome of 50 patients who underwent cranioplasty with a total of 53 OSSDSIGN Cranial implants. 64% of the patients […]